SCHEMBL2561345

SCHEMBL2561345

COc1ccc(C=O)cc1Oc1c[n+]([O-])ccc1N

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.53
TSHR P16473 1/20 0.53
TTR P02766 1/20 0.44
GAA P10253 1/20 0.44
FDPS P14324 1/20 0.43
HPGD P15428 4/20 0.42
AOX1 Q06278 1/20 0.42
TRIM24 O15164 1/20 0.42
ALDH5A1 P51649 1/20 0.42
ABAT P80404 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
TRIM33 Q9UPN9 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.40
MAPK1 P28482 1/20 0.40
MAPT P10636 2/20 0.40
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
PTGS2 P35354 1/20 0.39
CYP19A1 P11511 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2559258 0.82 ALDH1A1 (0.53) ALDH1A1TSHRTTRGAAFDPS
SCHEMBL2556917 0.81 ALDH1A1 (0.54) ALDH1A1TSHRTTRGAAHPGD
SCHEMBL7366005 0.78 ALDH1A1 (0.84) ALDH1A1TSHRTTRGAAFDPS
SCHEMBL21328335 0.75 ALDH1A1 (0.85) ALDH1A1TSHRTTRGAAFDPS
SCHEMBL10650056 0.75 ALDH1A1 (0.45) ALDH1A1TSHRGAATDP1MAPT
SCHEMBL2558102 0.74 ALDH1A1 (0.55) ALDH1A1TSHRTTRGAAFDPS
SCHEMBL2774349 0.74 ALDH1A1 (0.68) ALDH1A1TSHRTTRFDPSHPGD
SCHEMBL1869030 0.72 ALDH1A1 (0.84) ALDH1A1TSHRTTRFDPSHPGD
3,4-Dimethoxybenzaldehyde SCHEMBL5308959 0.72 ALDH1A1 (1.00) ALDH1A1TSHRTTRGAAFDPS
3,4-Dimethoxybenzaldehyde SCHEMBL25202 0.72 ALDH1A1 (1.00) ALDH1A1TSHRTTRGAAFDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011132051-A2 TRICYCLE COMPOUNDS AS PHOSPHODIESTERASE-10 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2011-10-27 WO disclosed